BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37466583)

  • 1. Central Adjudication Committee and Clinical Site Investigator Agreement on Outcomes in the PARITY Trial: A Secondary Analysis of the PARITY Trial Data.
    Slawaska-Eng D; Giglio V; Gazendam AM; Schneider P; Bernthal N; Ghert M;
    J Bone Joint Surg Am; 2023 Jul; 105(Suppl 1):73-78. PubMed ID: 37466583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Operative Treatment and Outcomes of Pediatric Patients with an Extremity Bone Tumor: A Secondary Analysis of the PARITY Trial Data.
    Bozzo A; Yeung CM; Van De Sande M; Ghert M; Healey JH;
    J Bone Joint Surg Am; 2023 Jul; 105(Suppl 1):65-72. PubMed ID: 37466582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient and Surgical Risk Factors for Surgical Site Infection in Lower-Extremity Oncological Endoprosthetic Reconstruction: A Secondary Analysis of the PARITY Trial Data.
    Slawaska-Eng D; Gazendam AM; Kendal J; Schneider P; Becker RG; Freitas JP; Bernthal N; Ghert M;
    J Bone Joint Surg Am; 2023 Jul; 105(Suppl 1):41-48. PubMed ID: 37466579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The inter-rater reliability of the diagnosis of surgical site infection in the context of a clinical trial.
    Nuttall J; Evaniew N; Thornley P; Griffin A; Deheshi B; O'Shea T; Wunder J; Ferguson P; Randall RL; Turcotte R; Schneider P; McKay P; Bhandari M; Ghert M
    Bone Joint Res; 2016 Aug; 5(8):347-52. PubMed ID: 27528711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical Duration Is Independently Associated with an Increased Risk of Surgical Site Infection and May Not Be Mitigated by Prolonged Antibiotics: A Secondary Analysis of the PARITY Trial of Infection After Lower-Extremity Endoprosthetic Reconstruction for Bone Tumors.
    Zeitlinger L; Wilson M; Randall RL; Thorpe S;
    J Bone Joint Surg Am; 2023 Jul; 105(Suppl 1):79-86. PubMed ID: 37466584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic Antibiotic Regimens In Tumor Surgery (PARITY): a multi-center randomized controlled study comparing alternative antibiotic regimens in patients undergoing tumor resections with endoprosthetic replacements-a statistical analysis plan.
    Schneider P; Heels-Ansdell D; Thabane L; Ghert M;
    Trials; 2021 Mar; 22(1):223. PubMed ID: 33752752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracavity lavage and wound irrigation for prevention of surgical site infection.
    Norman G; Atkinson RA; Smith TA; Rowlands C; Rithalia AD; Crosbie EJ; Dumville JC
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD012234. PubMed ID: 29083473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical Site Infection in Patients Managed with an Endoprosthesis for the Treatment of Cancer: Evaluation of Patient, Disease, and Index Surgical Factors.
    Ray GS; Werth P; Alexander JH; Eward WC; Bernthal NM; Jeys LM; Funovics P; Windhager R; Temple HT; Lozano-Calderon S; Avedian RS; Jutte PC; Ghert M; Ruggieri P; Henderson ER;
    J Bone Joint Surg Am; 2023 Jul; 105(Suppl 1):87-96. PubMed ID: 37466585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical antibiotics for preventing surgical site infection in wounds healing by primary intention.
    Heal CF; Banks JL; Lepper PD; Kontopantelis E; van Driel ML
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD011426. PubMed ID: 27819748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic antibiotics to prevent surgical site infection after breast cancer surgery.
    Gallagher M; Jones DJ; Bell-Syer SV
    Cochrane Database Syst Rev; 2019 Sep; 9(9):CD005360. PubMed ID: 31557310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic prophylaxis for the prevention of methicillin-resistant Staphylococcus aureus (MRSA) related complications in surgical patients.
    Gurusamy KS; Koti R; Wilson P; Davidson BR
    Cochrane Database Syst Rev; 2013 Aug; (8):CD010268. PubMed ID: 23959704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Negative pressure wound therapy for surgical wounds healing by primary closure.
    Norman G; Goh EL; Dumville JC; Shi C; Liu Z; Chiverton L; Stankiewicz M; Reid A
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD009261. PubMed ID: 32542647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Negative pressure wound therapy for surgical wounds healing by primary closure.
    Norman G; Goh EL; Dumville JC; Shi C; Liu Z; Chiverton L; Stankiewicz M; Reid A
    Cochrane Database Syst Rev; 2020 May; 5(5):CD009261. PubMed ID: 32356396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Prophylactic Intravenous Antibiotic Regimens After Endoprosthetic Reconstruction for Lower Extremity Bone Tumors: A Randomized Clinical Trial.
    ; Ghert M; Schneider P; Guyatt G; Thabane L; Vélez R; O'Shea T; Randall RL; Turcotte R; Wilson D; Wunder JS; Baptista AM; Cheng EY; Doung YC; Ferguson PC; Giglio V; Hayden J; Heels-Ansdell D; Khan SA; Sampath Kumar V; McKay P; Miller B; van de Sande M; Zumárraga JP; Bhandari M
    JAMA Oncol; 2022 Mar; 8(3):345-353. PubMed ID: 34989778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical Site Infection Is Not Associated with 1-Year Progression-Free Survival After Endoprosthetic Reconstruction for Lower-Extremity Osteosarcoma: A Secondary Analysis of PARITY Study Data.
    Jackson KJ; Sullivan CD; Zimel MN; Wustrack RL;
    J Bone Joint Surg Am; 2023 Jul; 105(Suppl 1):49-56. PubMed ID: 37466580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraoperative interventions for preventing surgical site infection: an overview of Cochrane Reviews.
    Liu Z; Dumville JC; Norman G; Westby MJ; Blazeby J; McFarlane E; Welton NJ; O'Connor L; Cawthorne J; George RP; Crosbie EJ; Rithalia AD; Cheng HY
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD012653. PubMed ID: 29406579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of prophylactic intraoperative vancomycin powder on microbial profile, antibiotic regimen, length of stay, and reoperation rate in elective spine surgery.
    Grabel ZJ; Boden A; Segal DN; Boden S; Milby AH; Heller JG
    Spine J; 2019 Feb; 19(2):261-266. PubMed ID: 29859351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does the Use of Negative Pressure Wound Therapy and Postoperative Drains Impact the Development of Surgical Site Infections?: A PARITY Trial Secondary Analysis.
    LiBrizzi CL; Sabharwal S; Forsberg JA; Leddy L; Doung YC; Morris CD; Levin AS;
    J Bone Joint Surg Am; 2023 Jul; 105(Suppl 1):34-40. PubMed ID: 37466578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three wound-dressing strategies to reduce surgical site infection after abdominal surgery: the Bluebelle feasibility study and pilot RCT.
    Reeves BC; Rooshenas L; Macefield RC; Woodward M; Welton NJ; Waterhouse BR; Torrance AD; Strong S; Siassakos D; Seligman W; Rogers CA; Rickard L; Pullyblank A; Pope C; Pinkney TD; Pathak S; Owais A; O'Callaghan J; O'Brien S; Nepogodiev D; Nadi K; Murkin CE; Munder T; Milne T; Messenger D; McMullan CM; Mathers JM; Mason M; Marshall M; Lovegrove R; Longman RJ; Lloyd J; Lim J; Lee K; Korwar V; Hughes D; Hill G; Harris R; Hamdan M; Brown HG; Gooberman-Hill R; Glasbey J; Fryer C; Ellis L; Elliott D; Dumville JC; Draycott T; Donovan JL; Cotton D; Coast J; Clout M; Calvert MJ; Byrne BE; Brown OD; Blencowe NS; Bera KD; Bennett J; Bamford R; Bakhbakhi D; Atif M; Ashton K; Armstrong E; Andronis L; Ananthavarathan P; Blazeby JM
    Health Technol Assess; 2019 Aug; 23(39):1-166. PubMed ID: 31392958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.